‘Enough sickness’ to share GP load among pharmacists, nurses

2 February 2023 - Pharmacy Guild of Australia president Trent Twomey says there is enough “demand and sickness” to allow ...

Read more →

FDA may not always require post-approval trials to be enrolled before accelerated approvals

30 January 2023 - A FDa official on Monday gave more clues for how the agency plans to wield new authority ...

Read more →

Options for a reformed Prostheses List pre-listing assessment framework and governance structure

31 January 2023 - This report provides a framework and proposes options for governance that would align the Prostheses List processes ...

Read more →

Draft methods (version 7.0): IQWiG is extending the comment period

26 January 2023 - The new deadline is 28 February 2023. ...

Read more →

The 4 biggest questions about the FDA’s forthcoming changes to accelerated approvals

25 January 2023 - Congress just boosted the FDA’s authority over the post-market clinical trials that are a condition of ...

Read more →

Reform Medicare to sustain system

25 January 2023 - Australia’s hybrid public/private healthcare system, including the principle of universal coverage through Medicare, has served the nation ...

Read more →

Updates from the Health Technology Assessment Policy and Methods Review Reference Committee

20 January 2023 - The Health Technology Assessment Policy and Methods Review Reference Committee held its first two meetings on 1 ...

Read more →

Consultation on the revised PBS post-market review framework – publication of responses

20 January 2023 - Consultation on a revised draft of the PBS post-market review framework was open from 20 October ...

Read more →

FDA’s breakthrough program: faster drug OKs without sacrificing safety

18 January 2023 - A FDA program markedly cut the time and cost of bringing to market new drugs, without ...

Read more →

PHARMAC's year in review leaves much to be desired

1 January 2023 - Christmas came early for a number of long-suffering patients. ...

Read more →

Prescription drug policy, 2022 and 2023: the year in review and the year ahead

9 January 2023 - This past year featured many significant developments in the prescription drug policy area, most notably the passage ...

Read more →

FDA cancer chief wants quicker ways to pull failed drugs

17 November 2022 - Makena highlights need to make system more nimble. ...

Read more →

Medicines industry calls for discount rate reduction now

18 November 2022 - Medicines Australia welcomes the recommendation to lower the discount rate for medicines and vaccines but questions ...

Read more →

Independent review into Medicare compliance

5 November 2022 - The Albanese Government has appointed respected health economist Dr Pradeep Philip to conduct an independent review into ...

Read more →

Health technology assessment review – frequently asked questions

27 October 2022 - The Department of Health & Aged Care has produced a two page summary on the upcoming ...

Read more →